Spiro Rombotis - Dec 21, 2023 Form 4 Insider Report for Cyclacel Pharmaceuticals, Inc. (CYCC)

Role: President and CEO, Director
Signature: /s/ Spiro Rombotis
Stock symbol: CYCC
Transactions as of: Dec 21, 2023
Transactions value $: $20,122
Form type: 4
Date filed: 12/26/2023, 04:05 PM
Previous filing: Jul 3, 2023

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	CYCC	Common Stock	Purchase	$20.1K	+6.07K	+9.7%	$3.32	68.7K	Dec 21, 2023	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	CYCC	Warrants (right to buy)	Purchase	$0	+6.07K		$0.00	6.07K	Dec 21, 2023	Common Stock	6.07K	$3.19	Direct	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The Reporting Person purchased unregistered shares of the Issuer's common stock in a private placement, pursuant to a Securities Purchase Agreement between the Reporting Person and the Issuer.
F2	Each share of common stock was purchased with an accompanying warrant at an aggregate purchase price of $3.315 per share and accompanying warrant.